However, when analyzing CD3+ or CD19+ cells in the circulation, there were significantly more CLL T cells after iv than ip injection, and more CLL B cells after ip than iv injection (Figure 7A). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.